Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice
Lynch syndrome (LS), also known as Hereditary Non-Polyposis Colorectal Cancer (HNPCC), is an autosomal dominant cancer syndrome which causes about 2–3% of cases of colorectal carcinoma. The development of LS is due to the genetic and epigenetic inactivation of genes involved in the DNA mismatch repa...
Main Authors: | Serena Ascrizzi, Grazia Maria Arillotta, Katia Grillone, Giulio Caridà, Stefania Signorelli, Asad Ali, Caterina Romeo, Pierfrancesco Tassone, Pierosandro Tagliaferri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/15/3930 |
Similar Items
-
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”
by: Katia Grillone, et al.
Published: (2020-06-01) -
The Effectiveness of Clinical Guidelines in the Diagnosis of Lynch Syndrome Compared to Microsatellite Instability and Immunohistochemistry Analyses in Southern Thailand
by: Thitipat Thavornpattanapong, et al.
Published: (2019-02-01) -
Case Report: Multiple colorectal cancers in a patient with Ulcerative colitis and Lynch syndrome: Is there a role for prophylactic colectomy? A short report and review of literature
by: Adewale Adeoba Ayeni, et al.
Published: (2022-12-01) -
Pulmonary sclerosing hemangioma in a 21-year-old male with metastatic hereditary non-polyposis colorectal cancer: Report of a case
by: Angele Martin K, et al.
Published: (2011-06-01) -
An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome
by: Therkildsen C, et al.
Published: (2021-05-01)